neohepatect
biotest pharma gmbh - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
rhophylac
csl behring gmbh - immunoglobulina anti-d (rh) - immunoglobulina anti-d (rh)
keyvenb
kedrion s.p.a. - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
niuliva
instituto grifols s.a. - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
rhesonativ
octapharma italy s.p.a. - immunoglobulina anti-d (rh) - immunoglobulina anti-d (rh)
vebiked
kedrion s.p.a. - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
kedhbs
kedrion s.p.a. - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
stagloban p +ce
idt biologika gmbh - immunoglobulina da cane, anticorpi contro la parvovirosi, anticorpi contro il cimurro, virus inattivato dell' epatite infettiva del cane - immunoglobulina da cane - 170 mg; anticorpi contro la parvovirosi - 1 : 10000; anticorpi contro il cimurro - 5000 ui; virus inattivato dell' epatite infettiva del cane - 1000 ui - canine distemper antiserum + canine adenovirus antiserum + canine parvovirus antiserum
flebogamma dif (previously flebogammadif)
instituto grifols s.a. - l'immunoglobulina umana normale - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - sieri immuni e immunoglobuline, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.
hyqvia
baxalta innovations gmbh - l'immunoglobulina umana normale - sindromi da immunodeficienza immunologica - sieri immuni e immunoglobuline, - la terapia sostitutiva in adulti, bambini e adolescenti (0-18 anni) in:primaria sindromi di immunodeficienza con alterata produzione di anticorpi. hypogammaglobulinaemia e infezioni batteriche ricorrenti in pazienti con leucemia linfocitica cronica (cll), in cui gli antibiotici profilattici hanno fallito o sono controindicati. hypogammaglobulinaemia e infezioni batteriche ricorrenti in pazienti con mieloma multiplo (mm) pazienti. hypogammaglobulinaemia in pazienti pre‑ e post‑trapianto allogenico di cellule staminali emopoietiche (hsct).